Company News: Pfizer invests in Boston-area hospitals, Centron takes on OraPharma
Making good on its global initiative to bolster science and academia, New York-based pharma giant Pfizer has announced plans to invest $100 million with Boston's Longwood Medical Area. The investment will be made over the next five years and includes the establishment of a resource space – to be called the Center for Therapeutic Innovation – which will create about 50 new jobs. The aim of the company's partnership with Boston-area hospitals and med schools is to shorten the gaps that occur in the R&D stages of drug development.
Medical communications agency Centron has announced an account win with oral health company OraPharma. The agency will oversee medical communications responsibilities for Arestin, a localized antibiotic used in periodontics. “We're very excited to be chosen to guide development and execution of medical communications for Arestin,” said Marcia McLaughlin, President & CEO of Centron, in a release. “Our staff is ready to join the OraPharma team and deliver the strategic excellence we strive for every day.”